SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-14-159986
Filing Date
2014-04-25
Accepted
2014-04-25 16:31:36
Documents
1
Group Members
VEF MANAGEMENT V, LLCVENROCK ASSOCIATES V, L.P.VENROCK ENTREPRENEURS FUND V, L.P.VENROCK MANAGEMENT V, LLCVENROCK PARTNERS MANAGEMENT V, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d717913dsc13g.htm SC 13G 141856
  Complete submission text file 0001193125-14-159986.txt   143606
Mailing Address 2494 SAN HILL RD SUITE 200 MENLO PARK CA 94025
Business Address 2494 SAN HILL RD SUITE 200 MENLO PARK CA 94025 650-561-9580
VENROCK PARTNERS V L P (Filed by) CIK: 0001395760 (see all company filings)

IRS No.: 000000000
Type: SC 13G

Mailing Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139
Business Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139 617-551-9600
Cerulean Pharma Inc. (Subject) CIK: 0001401914 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88094 | Film No.: 14786022
SIC: 2834 Pharmaceutical Preparations